The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Halofusol 0.5 mg/ml oral solution for calves

Laboratorios Karizoo S.A.VPA10786/007/001

Main Information

Trade NameHalofusol 0.5 mg/ml oral solution for calves
Active SubstancesHalofuginone
Dosage FormOral solution
Licence HolderLaboratorios Karizoo S.A.
License Holder AddressPol. Ind. La Borda
Mas Pujades, 11-12
08140 Caldes de Montbui
Licence NumberVPA10786/007/001

Group Information

ATC CodeQP51AX08 halofuginone
Therapeutic ClassCoccidiostats


License statusAuthorised
Licence Issued18/12/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back